Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


August 30, 2015 11:18 PM ET

Biotechnology

Company Overview of Cidara Therapeutics, Inc.

Executive Profile

Jeffrey Stein Ph.D.

Chief Executive, President and Executive Director, Cidara Therapeutics, Inc.
AgeTotal Calculated CompensationThis person is connected to 3 Board Members in 3 different organizations across 5 different industries.

See Board Relationships
60$871,598
As of Fiscal Year 2014

Background

Dr. Jeffrey Stein, also known as Jeff, Ph.D., has been Chief Executive and President of Cidara Therapeutics, Inc. since July 1, 2014. Dr. Stein serves as Principal Scientist of Verenium Corporation. Dr. Stein serves as Senior Vice President of Educational Strategy at MedCases, LLC. Dr. Stein was also founding Chairman and President of the Antibiotics Working Group. Dr. Stein served as the President and Chief Executive Officer of Trius Therapeutics Inc. since February ...

Corporate Headquarters

6310 Nancy Ridge Drive
San Diego, California 92121

United States

Phone: 858-752-6170
Fax: --

Board Members Memberships

Chief Executive, President and Executive Director
2005-Present
Chief Executive Officer, President and Executive Director
2014-Present
Director, Chairman of Compensation Committee, Member of Audit Committee and Member of Nominating & Corporate Governance Committee

Education

Bachelor's Degree
California State University
Master's Degree
California State University
PhD
University of California
PhD
Scripps Institution of Oceanography

Other Affiliations

Annual Compensation

Salary$263,846
Bonus$59,680
Total Annual Compensation$323,526

Stocks Options

Unexercisable Options$3,897,443
Total Number of Options$3,897,443

Total Compensation

Total Annual Cash Compensation$412,129
Total Short Term Compensation$323,526
Total Calculated Compensation$871,598
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Cidara Therapeutics, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.